Ovid Therapeutics Inc. (OVID)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 236.51M |
| Enterprise Value | 146.68M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 601.84 |
| Price/Book (mrq) | 2.69 |
| Enterprise Value/Revenue | 374.46 |
| Enterprise Value/EBITDA | -2.54 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.69 |
| 52-Week Change 3 | -7.22% |
| S&P500 52-Week Change 3 | 24.19% |
| 52 Week High 3 | 4.1390 |
| 52 Week Low 3 | 2.5700 |
| 50-Day Moving Average 3 | 3.1876 |
| 200-Day Moving Average 3 | 3.4256 |
Share Statistics
| Avg Vol (3 month) 3 | 210.09k |
| Avg Vol (10 day) 3 | 163.54k |
| Shares Outstanding 5 | 70.71M |
| Implied Shares Outstanding 6 | 70.81M |
| Float 8 | 37.59M |
| % Held by Insiders 1 | 15.97% |
| % Held by Institutions 1 | 64.57% |
| Shares Short (Apr 15, 2024) 4 | 2.8M |
| Short Ratio (Apr 15, 2024) 4 | 8.8 |
| Short % of Float (Apr 15, 2024) 4 | 4.83% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 3.96% |
| Shares Short (prior month Mar 15, 2024) 4 | 3.67M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -13,978.47% |
Management Effectiveness
| Return on Assets (ttm) | -24.76% |
| Return on Equity (ttm) | -47.57% |
Income Statement
| Revenue (ttm) | 391.69k |
| Revenue Per Share (ttm) | 0.01 |
| Quarterly Revenue Growth (yoy) | 205.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | -58.71M |
| Net Income Avi to Common (ttm) | -52.34M |
| Diluted EPS (ttm) | -0.7400 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 105.83M |
| Total Cash Per Share (mrq) | 1.5 |
| Total Debt (mrq) | 16M |
| Total Debt/Equity (mrq) | 18.23% |
| Current Ratio (mrq) | 9.55 |
| Book Value Per Share (mrq) | 1.24 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -45.78M |
| Levered Free Cash Flow (ttm) | -25.92M |
© 2024 Yahoo. All rights reserved.